跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOCOVID SUPRABIO SOFT GELATIN CAPSULE 228mg - NPRA Drug Approval Details
Approvals
/
NPRA
/
TOCOVID SUPRABIO SOFT GELATIN CAPSULE 228mg
Approved
STANDARD
TOCOVID SUPRABIO SOFT GELATIN CAPSULE 228mg
HOVID BERHAD
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
708854f77ca239e1
Company
HOVID BERHAD
Type
Standard
Approval Details
Approval Id
708854f77ca239e1
Drug Approval Npra Name
TOCOVID SUPRABIO SOFT GELATIN CAPSULE 228mg
Product Name
TOCOVID SUPRABIO SOFT GELATIN CAPSULE 228mg
Registration Number
MAL20172957NR
Holder Company Name
HOVID BERHAD
Holder Company Detail Path
/organization/hovid-berhad
Holder Address
121, JALAN TUNKU ABDUL RAHMAN (JALAN KUALA KANGSAR) 30010 IPOH MALAYSIA
Holder Phone
05-5060690
Manufacturer Company Name
HOVID BERHAD
Manufacturer Company Detail Path
/organization/hovid-berhad
Manufacturer Address
121 JALAN TUNKU ABDUL RAHMAN (JALAN KUALA KANGSAR) 30010 IPOH MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL20172957NR
Version
1751614591
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
708854f77ca239e1
Type
Standard
Source
Official Source
Back to NPRA Approvals